CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease

By Blennow Kaj   Vanmechelen Eugeen   Hampel Harald  

Molecular Neurobiology, Vol. 24, Iss. 1-3, 2001-08 ,pp. : 87-97

Humana Press, Inc

Access to resources Recommend Favorite

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’’s disease and other dementias

By Abraham Jean-Daniel   Calvayrac-Pawlowski Sophie   Cobo Sandra   Salvetat Nicolas   Vicat Guillaume   Molina Laurence   Touchon Jacques   Michel Bernard-Franççois   Molina Franck   Verdier Jean-Michel   Fareh Jeannette   Mourton-Gilles Chantal  

Biomarkers, Vol. 16, Iss. 2, 2011-03 ,pp. : 161-171

Informa Healthcare

Access to resources Recommend Favorite

SSeCKS promote beta-amyloid-induced PC12 cells neurotoxicity by up-regulating tau phosphorylation in Alzheimer’s disease

By Cui Zhiming   Tao Tao   Cheng Chun   Yang Junling   Shen Qin   Ji Yuhong   Li Xiaohong   Liu Haiou   Shen Aiguo   Lu Xiang  

Molecular and Cellular Biochemistry, Vol. 340, Iss. 1-2, 2010-07 ,pp. : 257-263

Springer Publishing Company

Access to resources Recommend Favorite

Solanezumab for Alzheimer's disease

By Samadi Hossein   Sultzer David  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 787-798

Informa Healthcare

Access to resources Recommend Favorite

Gantenerumab for the treatment of Alzheimer's disease

By Delrieu Julien   Ousset Pierre Jean   Vellas Bruno  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1077-1086

Informa Healthcare

Access to resources Recommend Favorite